{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T22:07:50Z","timestamp":1778018870138,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jneuroim.2013.07.012","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T12:27:59Z","timestamp":1374755279000},"page":"35-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Mu opioid receptor agonist-selective regulation of interleukin-4 in T lymphocytes"],"prefix":"10.1016","volume":"263","author":[{"given":"Christine","family":"B\u00f6rner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Lanciotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"H\u00f6llt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2013.07.012_bb0025","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/j.1471-4159.2004.02846.x","article-title":"STAT6 transcription factor binding sites with mismatches within the canonical 5\u2032-TTC\u2026GAA-3\u2032 motif involved in regulation of delta- and mu-opioid receptors","volume":"91","author":"Borner","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0005","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1124\/mol.105.018325","article-title":"Cannabinoid receptor type 2 agonists induce transcription of the \u03bc-opioid receptor gene in Jurkat T cells","volume":"69","author":"Borner","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jneuroim.2007.05.007","article-title":"Comparative analysis of mu-opioid receptor expression in immune and neuronal cells","volume":"188","author":"Borner","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0010","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1124\/mol.108.046029","article-title":"T cell receptor\/CD28-mediated activation of human T lymphocytes induces expression of functional {micro}-opioid receptors","volume":"74","author":"Borner","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0020","doi-asserted-by":"crossref","first-page":"882","DOI":"10.4049\/jimmunol.0802763","article-title":"Mechanisms of opioid-mediated inhibition of human T cell receptor signaling","volume":"183","author":"Borner","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0030","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s11481-011-9290-7","article-title":"Immunosuppressive effects of opioids\u2014clinical relevance","volume":"6","author":"Brack","year":"2011","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0035","doi-asserted-by":"crossref","first-page":"18081","DOI":"10.1074\/jbc.M513640200","article-title":"Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes","volume":"281","author":"Bruchas","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0040","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1476-5381.2011.01382.x","article-title":"Agonist-selective patterns of micro-opioid receptor phosphorylation revealed by phosphosite-specific antibodies","volume":"164","author":"Doll","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11481-006-9019-1","article-title":"Effects of opioid tolerance and withdrawal on the immune system","volume":"1","author":"Eisenstein","year":"2006","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0162-3109(00)00198-3","article-title":"Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray","volume":"48","author":"Gomez-Flores","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0055","doi-asserted-by":"crossref","first-page":"19021","DOI":"10.1074\/jbc.271.32.19021","article-title":"Morphine activates opioid receptors without causing their rapid internalization","volume":"271","author":"Keith","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.tips.2007.06.009","article-title":"Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors","volume":"28","author":"Kenakin","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0065","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0301-0082(02)00008-4","article-title":"Exploring the opioid system by gene knockout","volume":"66","author":"Kieffer","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0070","doi-asserted-by":"crossref","first-page":"9979","DOI":"10.1074\/jbc.M206709200","article-title":"ADP-ribosylation factor-dependent phospholipase D2 activation is required for agonist-induced mu-opioid receptor endocytosis","volume":"278","author":"Koch","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0075","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1471-4159.2006.03736.x","article-title":"Role of phospholipase D2 in the agonist-induced and constitutive endocytosis of G-protein coupled receptors","volume":"97","author":"Koch","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0080","doi-asserted-by":"crossref","first-page":"43901","DOI":"10.1074\/jbc.M107543200","article-title":"Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site","volume":"276","author":"Kraus","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0085","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1124\/mol.64.4.876","article-title":"The role of nuclear factor {kappa}B in tumor necrosis factor-regulated transcription of the human {micro}-opioid receptor gene","volume":"64","author":"Kraus","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0090","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1096\/fj.02-0482fje","article-title":"Distinct palindromic extensions of the 5\u2032-TTC\u2026GAA-3\u2032 motif allow STAT6 binding in vivo","volume":"17","author":"Kraus","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.molimm.2010.08.002","article-title":"Epigenetic mechanisms involved in the induction of the mu opioid receptor gene in Jurkat T cells in response to interleukin-4","volume":"48","author":"Kraus","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0100","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.cellsig.2006.03.015","article-title":"Tracking the opioid receptors on the way of desensitization","volume":"18","author":"Marie","year":"2006","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.pain.2004.04.020","article-title":"Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses","volume":"110","author":"Martucci","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0110","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.neuroscience.2005.11.046","article-title":"Mu-opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists omparison between etorphine and morphine","volume":"138","author":"Narita","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0115","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0962-8924(00)01856-0","article-title":"The molecular basis of T helper 1 and T helper 2 cell differentiation","volume":"10","author":"O'Garra","year":"2000","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0120","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1172\/JCI113140","article-title":"Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells","volume":"80","author":"Peterson","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0125","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/infdis\/159.3.480","article-title":"Suppression of human peripheral blood mononuclear cell function by methadone and morphine","volume":"159","author":"Peterson","year":"1989","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1568026043451519","article-title":"Expression of opioid receptors during peripheral inflammation","volume":"4","author":"Pol","year":"2004","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/cimm.1997.1147","article-title":"Morphine inhibits transcriptional activation of IL-2 in mouse thymocytes","volume":"179","author":"Roy","year":"1997","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0135","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1067\/msy.2001.116033","article-title":"Morphine directs T cells toward T(H2) differentiation","volume":"130","author":"Roy","year":"2001","journal-title":"Surgery"},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jneuroim.2003.10.016","article-title":"Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet","volume":"147","author":"Roy","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0145","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.4049\/jimmunol.175.10.6361","article-title":"Morphine induces CD4+ T cell IL-4 expression through an adenylyl cyclase mechanism independent of the protein kinase A pathway","volume":"175","author":"Roy","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11481-005-9009-8","article-title":"Modulation of immune function by morphine: implications for susceptibility to infection","volume":"1","author":"Roy","year":"2006","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/SPC.0b013e3282f5272e","article-title":"Opioid-induced immunosuppression","volume":"2","author":"Sacerdote","year":"2008","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0170","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/sj.bjp.0701138","article-title":"Antinociceptive and immunosuppressive effects of opioid drugs: a structure-related activity study","volume":"121","author":"Sacerdote","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0165","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood.V95.6.2031","article-title":"The opioid antagonist naloxone induces a shift from type 2 to type 1 cytokine pattern in BALB\/cJ mice","volume":"95","author":"Sacerdote","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0175","doi-asserted-by":"crossref","first-page":"9988","DOI":"10.1073\/pnas.0804246105","article-title":"Distinct conformational changes in beta-arrestin report biased agonism at seven-transmembrane receptors","volume":"105","author":"Shukla","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0180","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0306-3623(94)00162-G","article-title":"Direct cellular immunomodulation produced by diacetylmorphine (heroin) or methadone","volume":"26","author":"Thomas","year":"1995","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology","volume":"320","author":"Urban","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0190","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1073\/pnas.89.9.4076","article-title":"Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist","volume":"89","author":"Vannier","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0195","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0200","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4049\/jimmunol.123.3.1068","article-title":"Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes","volume":"123","author":"Wybran","year":"1979","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0205","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/mol.109.063107","article-title":"Role of phospholipase D2\/phosphatidic acid signal transduction in micro- and delta-opioid receptor endocytosis","volume":"78","author":"Yang","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0210","doi-asserted-by":"crossref","first-page":"7157","DOI":"10.1073\/pnas.95.12.7157","article-title":"Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness","volume":"95","author":"Zhang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0215","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s11481-012-9396-6","article-title":"Regulation of mu opioid receptor expression in developing T cells","volume":"7","author":"Zhang","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0220","doi-asserted-by":"crossref","first-page":"9421","DOI":"10.1073\/pnas.0802253105","article-title":"Agonist-selective signaling is determined by the receptor location within the membrane domains","volume":"105","author":"Zheng","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0225","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1124\/mol.107.039842","article-title":"Beta-arrestin-dependent mu-opioid receptor-activated extracellular signal-regulated kinases (ERKs) translocate to nucleus in contrast to G protein-dependent ERK activation","volume":"73","author":"Zheng","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jneuroim.2013.07.012_bb0230","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/mol.109.060848","article-title":"mu-Opioid receptor agonists differentially regulate the expression of miR-190 and NeuroD","volume":"77","author":"Zheng","year":"2010","journal-title":"Mol. Pharmacol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813001963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813001963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:21:16Z","timestamp":1759047676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572813001963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":46,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0165572813001963"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.07.012","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mu opioid receptor agonist-selective regulation of interleukin-4 in T lymphocytes","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}